BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
221 results:

  • 1. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
    Lv M; Li X; Yin Z; Yang H; Zhou B
    PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Next-Generation Sequencing in lung cancers-A Single-Center Experience in Taiwan.
    Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
    [No Abstract]    [Full Text] [Related]  

  • 4. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic characteristics and immune landscape of super multiple primary lung cancer.
    Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
    EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
    Menzel M; Kirchner M; Kluck K; Ball M; Beck S; Allgäuer M; Assmann C; Schnorbach J; Volckmar AL; Tay TKY; Goldschmid H; Tan DS; Thomas M; Kazdal D; Budczies J; Stenzinger A; Christopoulos P
    J Pathol Clin Res; 2024 Mar; 10(2):e354. PubMed ID: 38284983
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report.
    Peng Y; Zheng Z; Zewen W; Yanan L; Mingyan Z; Meili S
    BMC Pulm Med; 2023 Dec; 23(1):492. PubMed ID: 38057798
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
    Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
    [No Abstract]    [Full Text] [Related]  

  • 9. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
    Yin D; Zhang Y; Li H; Cheng L
    Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With
    Ito S; Tsurumi K; Shindo N; Soma S; Yamaguchi K; Tamai K; Mochizuki M; Fujimori H; Morita M; Watanabe K; Suzuki A; Fukuhara T; Yasuda J
    Anticancer Res; 2023 Nov; 43(11):5031-5040. PubMed ID: 37909987
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
    Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
    J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The XRCC1 and tp53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
    Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
    J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Unmet Diagnostic and Treatment Needs in Large cell Neuroendocrine Carcinoma of the lung.
    Buium C; Negru S; Ionescu DN; Dediu M
    Curr Oncol; 2023 Jul; 30(8):7218-7228. PubMed ID: 37623004
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
    Seker-Cin H; Tay TKY; Kazdal D; Kluck K; Ball M; Neumann O; Winter H; Herth F; Heußel CP; Savai R; Schirmacher P; Thomas M; Budczies J; Allgäuer M; Christopoulos P; Stenzinger A; Volckmar AL
    Lung Cancer; 2023 Oct; 184():107317. PubMed ID: 37586177
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.
    Latham K; Dong F
    Am J Clin Pathol; 2023 Nov; 160(5):533-539. PubMed ID: 37543867
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
    Smyth EN; John J; Tiu RV; Willard MD; Beyrer JK; Bowman L; Sheffield KM; Han Y; Brastianos PK
    Oncologist; 2023 Nov; 28(11):e1075-e1091. PubMed ID: 37358877
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
    Megyesfalvi Z; Gay CM; Popper H; Pirker R; Ostoros G; Heeke S; Lang C; Hoetzenecker K; Schwendenwein A; Boettiger K; Bunn PA; Renyi-Vamos F; Schelch K; Prosch H; Byers LA; Hirsch FR; Dome B
    CA Cancer J Clin; 2023; 73(6):620-652. PubMed ID: 37329269
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The role of biomarkers in stage III non-small cell lung cancer.
    Rosell R; González-Cao M; Ito M; Santarpia M; Aguilar A; Codony-Servat J
    Expert Rev Respir Med; 2023; 17(6):469-480. PubMed ID: 37317885
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Recent progress of biosensors for the detection of lung cancer markers.
    Chen S; Li M; Weng T; Wang D; Geng J
    J Mater Chem B; 2023 Jun; 11(25):5715-5747. PubMed ID: 37264815
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.